The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
Rather than just waiting for your hay fever symptoms to arrive then treating them with medicines, airborne allergens expert, Max Wiseberg, recommends a more holistic and natural approach to the problem.
Dr Shiksha Gallow, Medical Director of Biodata and Head Researcher at Cannabis Oil Research, provides evidence-based research on cannabinoids for treating MS and Prostate Cancer.
Daniel Berman, Head of Global Health, Nesta Challenges, highlights the need for radical change in how innovation is funded and prioritised to ensure an antibiotic future given AMR is still climbing, even though behaviours are changing.
Dr. Jo Gee writes about working with personality disorders through her psychotherapy experience of over 10 years: Read on for what she has to say about mental health treatment.
The role of vitamin D in pregnancy is an example of work by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, investigating human development.
Peter Kinderman, Professor of Clinical Psychology at the University of Liverpool and member of Mental Health Europe, argues that labels are for products and not for people, as he focuses on psychological assessment.
Following the first two articles that discussed the treatment of cancer and pain, this third piece will focus on the use of cannabinoids to treat psoriasis and rheumatoid arthritis.
However, the majority of clinical standards for diagnosis and treatment in modern oncology are traditionally birthed solely from biological investigations.
Rich Pugh, Chief Data Scientist at Mango Solutions, discusses how data science can be used for good, with a particular focus on the provision of medication and helping create a more efficient NHS.
